Trading Members of the Exchange are hereby informed that effective from July 16, 2025, the equity shares of Asston Pharmaceuticals Ltd (Scrip Code: 544445) are listed and admitted to dealings ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals Ltd has been listed on BSE with Scrip Code 544445, effective July 16, 2025. The company's equity shares are now admitted to dealings on the exchange, meaning retail and institutional investors can begin trading the stock from this date. This is a routine exchange notification confirming trading commencement following the company's listing process.
Shares of Asston Pharmaceuticals Ltd will be available for buying and selling on BSE starting July 16, 2025. Early trading days often see volatility as the market establishes a fair price, so investors should monitor price action closely before taking positions.